ZA943203B - Method of lowering blood lipid levels - Google Patents

Method of lowering blood lipid levels

Info

Publication number
ZA943203B
ZA943203B ZA943203A ZA943203A ZA943203B ZA 943203 B ZA943203 B ZA 943203B ZA 943203 A ZA943203 A ZA 943203A ZA 943203 A ZA943203 A ZA 943203A ZA 943203 B ZA943203 B ZA 943203B
Authority
ZA
South Africa
Prior art keywords
blood lipid
lowering blood
lipid levels
levels
lowering
Prior art date
Application number
ZA943203A
Other languages
English (en)
Inventor
Michael J Peterson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA943203B publication Critical patent/ZA943203B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA943203A 1993-05-10 1994-05-09 Method of lowering blood lipid levels ZA943203B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/059,688 US5391551A (en) 1993-05-10 1993-05-10 Method of lowering blood lipid levels

Publications (1)

Publication Number Publication Date
ZA943203B true ZA943203B (en) 1995-11-09

Family

ID=22024600

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943203A ZA943203B (en) 1993-05-10 1994-05-09 Method of lowering blood lipid levels

Country Status (10)

Country Link
US (1) US5391551A (cs)
EP (1) EP0624369A1 (cs)
JP (1) JP3153070B2 (cs)
KR (1) KR0140146B1 (cs)
CN (1) CN1047520C (cs)
AU (1) AU657444B2 (cs)
CA (1) CA2123059C (cs)
IL (1) IL109517A (cs)
TW (1) TW235919B (cs)
ZA (1) ZA943203B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834466A (en) * 1994-12-22 1998-11-10 The Regents Of The University Of California Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia
IL120264A0 (en) * 1996-02-29 1997-06-10 Pfizer Method of reducing tissue damage associated with non-cardiac ischemia
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
UA57811C2 (uk) * 1997-11-21 2003-07-15 Пфайзер Продактс Інк. Фармацевтична композиція, що містить інгібітор альдозоредуктази та інгібітор глікогенфосфорилази (варіанти), комплект, який її включає, та способи лікування ссавців зі станом інсулінорезистентності
KR100584650B1 (ko) 1998-03-31 2006-05-30 디 인스티튜트스 포 파마슈티컬 디스커버리, 엘엘씨 치환된 인돌알칸산
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
JP6244425B2 (ja) * 2016-08-18 2017-12-06 花王株式会社 Ｇｌｐ−１分泌促進剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492706A (en) * 1983-08-01 1985-01-08 American Home Products Corporation Method of lowering lipid levels
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
EP0310931A3 (en) * 1987-10-08 1990-10-03 Ethyl Corporation Poultry feed
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels

Also Published As

Publication number Publication date
AU657444B2 (en) 1995-03-09
JP3153070B2 (ja) 2001-04-03
CN1047520C (zh) 1999-12-22
JPH08165241A (ja) 1996-06-25
IL109517A0 (en) 1994-08-26
CN1103783A (zh) 1995-06-21
KR0140146B1 (ko) 1998-06-01
AU6196694A (en) 1994-12-01
TW235919B (cs) 1994-12-11
CA2123059A1 (en) 1994-11-11
EP0624369A1 (en) 1994-11-17
CA2123059C (en) 1997-01-21
IL109517A (en) 1998-08-16
US5391551A (en) 1995-02-21

Similar Documents

Publication Publication Date Title
PL310548A1 (en) Method of burnishing structure components
PL297904A1 (en) Method of obtaining bisephenol
IL106255A0 (en) Method for isolating human blood cells
PL313740A1 (en) Method of
IL109517A0 (en) Method of lowering blood lipid levels
PL305237A1 (en) Method of obtaining 3-aminopyridines from 3-nitropyridines
HUP9802706A3 (en) Method for the microbial decontamination of blood platelets
PL297500A1 (en) Method of obtaining 4-phenyl-benzophenone
PL310620A1 (en) Method of obtaining condenset carbapenemic derivatives
PL301929A1 (en) Method of obtaining epichlorohydine
HU9301041D0 (en) Method for producing new tri-substituted cycloalcane derivatives and medical preparatives containing them
PL310521A1 (en) Method of obtaining alkylbenzenosulphonic acid
PL299255A1 (en) Method of obtaining meproscilarine
IL107586A0 (en) Method for treatment of blood
IL107015A0 (en) Method for treatment of blood
HU209549B (en) Method for making of poliurethane-foam coffin
PL300899A1 (en) Method of obtaining esters
ZA942247B (en) Method of construction
GB9321796D0 (en) Method of treatment
GB9321971D0 (en) Method of treatment
PL297498A1 (en) Method of obtaining novel derivatives of 1-aryl-2-imine 3-aryl-sulfonyl imidazolydine
PL301647A1 (en) Method of obtaining adsorbents
PL292318A1 (en) Method of obtaining 7-hydroxy-4-methylcoumarin
PL299879A1 (en) Method of obtaining modified elastomers
PL299565A1 (en) Method of obtaining pure staphylococcin t